Suppr超能文献

中药复方联合化疗治疗晚期结直肠癌的疗效和安全性:系统评价和荟萃分析方案。

Efficacy and safety of traditional Chinese medicine decoction combined with chemotherapy in the treatment of advanced colorectal cancer: A protocol of a systematic review and meta-analysis.

机构信息

School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine.

School of Acupuncture-Moxibustion and Tuina, The Third Affiliated Hospital, Chengdu University of Traditional Chinese Medicine.

出版信息

Medicine (Baltimore). 2021 Jan 22;100(3):e23952. doi: 10.1097/MD.0000000000023952.

Abstract

BACKGROUND

Colorectal cancer has become a major chronic and difficult disease endangering human health. After thousands of years of precipitation, traditional Chinese medicine in China is now also being applied in clinical treatment, with its unique advantages in the treatment of cancer. However, the efficacy of traditional Chinese medicine in the treatment of advanced colorectal cancer still cannot reach consensus in the world. Therefore, the aim of this study was to provide a scheme to evaluate the efficacy and safety of traditional Chinese medicine decoction in the treatment of advanced colorectal cancer, thus providing clinical decision-making.

METHODS AND ANALYSIS

The systematic review and meta-analysis will be conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. The following 8databases will be searched: China National Knowledge Infrastructure (CNKI), China Biology Medicine (CBM), Wan Fang Data, the Chinese Science and Technology Periodical Database (VIP), PubMed, Cochrane Library, Embase, and Web of Science. Relevant data will be performed by Revman 5.3 software provided (Cochrane Collaboration) and Stata 14.0 statistical software.

RESULTS

The results of this systematic review and meta-analysis will be published in a peer-reviewed journal.

INPLASY REGISTRATION NUMBER

INPLASY202080102.

摘要

背景

结直肠癌已成为危害人类健康的重大慢性难治性疾病。经过几千年的沉淀,我国的中医药目前也已应用于临床治疗,在癌症治疗方面具有独特的优势。然而,中医药治疗晚期结直肠癌的疗效在世界范围内仍未达成共识。因此,本研究旨在提供一种评估中药汤治疗晚期结直肠癌的疗效和安全性的方案,从而为临床决策提供依据。

方法与分析

本系统评价和荟萃分析将按照《系统评价和荟萃分析首选报告项目(PRISMA)》指南进行。将检索以下 8 个数据库:中国知网(CNKI)、中国生物医学文献数据库(CBM)、万方数据、中文科技期刊数据库(VIP)、PubMed、Cochrane 图书馆、Embase 和 Web of Science。相关数据将由 Cochrane 协作网提供的 RevMan 5.3 软件(Cochrane 协作网)和 Stata 14.0 统计软件进行分析。

结果

本系统评价和荟萃分析的结果将发表在同行评议的期刊上。

INPLASY 注册号:INPLASY202080102。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de9c/7837827/28c851d2b1a5/medi-100-e23952-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验